Treatment of unstable angina pectoris/non-ST-segment elevation myocardial infarction in elderly patients
1Department of Medicine, New York Medical College, Valhalla 10595, USA. wsaronow@aol.com
Insights
Elderly patients with unstable angina or non-ST-segment elevation myocardial infarction require prompt hospitalization and aggressive medical management. Key treatments include aspirin, clopidogrel, beta-blockers, ACE inhibitors, and statins, with risk factor modification crucial for long-term outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Geriatrics
Background:
- Unstable angina pectoris and non-ST-segment elevation myocardial infarction are critical cardiovascular conditions.
- Elderly patients present unique challenges in managing acute coronary syndromes.
Purpose of the Study:
- To outline optimal management strategies for elderly patients with unstable angina/non-ST-segment elevation myocardial infarction.
- To provide evidence-based recommendations for pharmacological and interventional treatments.
Main Methods:
- Review of current clinical guidelines and evidence for managing acute coronary syndromes in the elderly.
- Emphasis on early diagnosis, risk stratification, and tailored therapeutic interventions.
- Inclusion of recommendations for long-term risk factor modification and secondary prevention.
Main Results:
- Hospitalization is essential, with immediate administration of aspirin and consideration of clopidogrel.
- Beta-blockers, ACE inhibitors, and statins are recommended for indefinite use.
- Invasive strategies like percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABGS) are indicated for high-risk patients.
- Intra-aortic balloon pump counterpulsation is reserved for severe, refractory ischemia or hemodynamic instability.
- Intensive risk factor modification post-discharge is critical for improving outcomes.
Conclusions:
- A comprehensive, multi-faceted approach is necessary for managing elderly patients with unstable angina/non-ST-segment elevation myocardial infarction.
- Early and aggressive medical therapy, combined with appropriate revascularization and long-term risk factor control, improves prognosis.
- Individualized treatment plans considering patient-specific factors are paramount for optimal care.
Abstract:
Elderly patients with unstable angina pectoris/non-ST-segment elevation myocardial infarction should be hospitalized. Precipitating factors should be identified and corrected. Electrocardiogram monitoring is important. Aspirin should be given as soon as possible and continued indefinitely. Clopidogrel should given for up to 9 months in patients in whom an early noninterventional approach is planned or in whom a percutaneous coronary intervention (PCI) is planned. Clopidogrel should be withheld for 5-7 days in patients in whom elective coronary artery bypass graft surgery (CABGS) is planned. A platelet glycoprotein IIb/IIIa inhibitor should also be given in addition to aspirin, clopidogrel, and heparin in patients in whom cardiac catheterization and PCI are planned. Patients whose symptoms are not fully relieved with three 0.4-mg sublingual nitroglycerin tablets or spray taken 5 minutes apart and the initiation of an intravenous beta blocker should be treated with continuous intravenous nitroglycerin. Beta blockers and angiotensin-converting enzyme (ACE) inhibitors should be given and continued indefinitely. The benefit of long-acting nondihydropyridine calcium channel blockers is limited to symptom control. Intra-aortic balloon pump counterpulsation should be used for severe ischemia that is continuing or occurs frequently despite intensive medical therapy or for hemodynamic instability. Statins should be used if the serum low-density lipoprotein (LDL) cholesterol is >or=100 mg/dl and continued indefinitely. Enoxaparin is preferable to intravenous unfractionated heparin in the absence of renal failure and unless CABGS is planned within 24 hours. Thrombolysis is not beneficial. High-risk patients should have an early invasive strategy with CABGS or PCI performed depending on the coronary artery anatomy, left ventricular function, presence or absence of diabetes, and findings on noninvasive testing. Following hospital discharge, patients should have intensive risk factor modification with cessation of smoking, maintenance of blood pressure below 135/85 mmHg, indefinite use of statins if needed to maintain the serum LDL cholesterol <100 mg/dl, intensive control of diabetes, maintenance of optimal weight, and daily exercise. Patients should be treated indefinitely with aspirin, beta blockers, and ACE inhibitors and with clopidogrel for up to 9 months. Nitrates should be given for ischemic symptoms. Hormonal therapy should not be given to postmenopausal women.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification
Angina IV: Management
Angina V: Nursing Management
